- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gulf Pharm Ind (JULPHAR)
The Gulf Pharm Ind share price today is 1.050, view ADX JULPHAR stock exchange data. Track the latest Gulf Pharm Ind share price with real-time updates on JULPHAR stock performance including market cap, day range, 52-week range and dividend yield. Access JULPHAR charts, earnings dates and analyst estimates to support your investment decisions.
Abu Dhabi
Currency in AED
1.050
-0.020(-1.87%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.050
1.070
52 wk Range
0.956
1.470
JULPHAR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0501.070
52 wk Range
0.9561.470
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JULPHAR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1.530
Upside
+45.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.530
(+45.71% Upside)
Earnings
Latest Release
13-08-2026
EPS / Forecast
0.03 / --
Revenue / Forecast
300.3M / --
Compare JULPHAR to Peers and Sector
Metrics to compare | JULPHAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJULPHARPeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.8x | 15.7x | −0.3x | |
PEG Ratio | −0.29 | −0.16 | 0.00 | |
Price/Book | 1.2x | 4.3x | 2.6x | |
Price / LTM Sales | 1.1x | 2.4x | 3.1x | |
Upside (Analyst Target) | 43.0% | 36.0% | 50.4% | |
Fair Value Upside | Unlock | 6.4% | 6.4% | Unlock |
Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wound care management, dermatology, endocrine, gynecology and women care, anemia, antibiotics, decongestants and other nasal preparations, hyperkalemia and hyperphosphatemia, urinary antispasmodics, erectile dysfunction, benign prostatic hyperplasia, and gastrointestinal tract. The company is also involved in transportation activities; general trading; distribution, wholesale, and retail trading of medicines and cosmetic products; facilities management services, health treatment undertaking services, and hospitals management; investment in commercial, industrial, and healthcare enterprises; agent; sale of cosmetics; export and import activities; and trading in medical equipment. Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is headquartered in Ras al-Khaimah, the United Arab Emirates.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Gulf Pharm Ind (JULPHAR) Share Price Today?
The Gulf Pharm Ind share price today is 1.050.
What is the current Gulf Pharm Ind (JULPHAR) share price and day range?
As of 20-08-2026, the Gulf Pharm Ind share price is 1.050, with a previous close of 1.330. The share price has ranged from 1.050 to 1.070 today, while the 52-week range spans from 0.956 to 1.470.
What Is the Gulf Pharm Ind Market Cap?
As of today, Gulf Pharm Ind market cap is 1.210B.
What Is the Gulf Pharm Ind (JULPHAR) Share Price Target?
The average 12-month share price target for Gulf Pharm Ind is 1.530, with a high estimate of 1.53 and a low estimate of 1.53. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +45.71% Upside potential.
What Is Gulf Pharm Ind's Earnings Per Share (TTM)?
The Gulf Pharm Ind EPS (TTM) is 0.082.
When Is the Next Gulf Pharm Ind Earnings Date?
Gulf Pharm Ind will release its next earnings report on 05-11-2026.
From a Technical Analysis Perspective, Is JULPHAR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Gulf Pharm Ind Trade On?
Gulf Pharm Ind is listed and trades on the Abu Dhabi.
What Is the Stock Symbol for Gulf Pharm Ind?
The stock symbol for Gulf Pharm Ind is "JULPHAR."
How Many Times Has Gulf Pharm Ind Stock Split?
Gulf Pharm Ind has split 15 times.
How Many Employees Does Gulf Pharm Ind Have?
Gulf Pharm Ind has 2400 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.